Cresco Labs (CRLBF) to Post Earnings on Thursday

Cresco Labs (OTCMKTS:CRLBF) is projected to announce its results before the market opens on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $166.1970 million for the quarter.

Cresco Labs (OTCMKTS:CRLBF) last announced its quarterly earnings data on Friday, May 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Cresco Labs had a negative return on equity of 17.98% and a negative net margin of 20.90%.The firm had revenue of $151.32 million during the quarter, compared to analysts’ expectations of $148.58 million. On average, analysts expect Cresco Labs to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Cresco Labs Trading Up 6.0%

Cresco Labs stock opened at $0.68 on Tuesday. The stock has a 50-day moving average price of $0.80 and a 200 day moving average price of $0.93. The company has a market capitalization of $341.83 million, a price-to-earnings ratio of -1.74 and a beta of 1.54. Cresco Labs has a 52 week low of $0.54 and a 52 week high of $2.30. The company has a quick ratio of 1.41, a current ratio of 2.51 and a debt-to-equity ratio of 1.78.

About Cresco Labs

Cresco Labs is a vertically integrated, multi-state cannabis operator in the United States. The company engages in the cultivation, manufacturing and distribution of a broad range of cannabis products, including flower, pre-rolled joints, concentrates, vaporizers, edibles and tinctures. Cresco Labs’ operations span cultivation facilities, processing laboratories and a network of wholesale distribution centers that supply licensed dispensaries and retail outlets across key cannabis markets.

The company’s product portfolio is organized under several branded platforms, such as MÜV, Reserve and High Supply, each designed to address different segments of the adult-use and medical cannabis markets.